Using SP1 antibody, we next performed Western blotting of 116 ERα-positive breast tumor samples (initially characterized with the 6 F11 or 1D5 antibodies) to compare the relative abundance of ERα46 and ERα66. The gene discussed is ESR1; the disease is breast neoplasm.